QTTB
Price
$8.24
Change
-$0.01 (-0.12%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
274.77M
34 days until earnings call
Intraday BUY SELL Signals
STOK
Price
$25.65
Change
-$0.36 (-1.38%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.65B
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

QTTB vs STOK

QTTB vs STOK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
QTTB vs. STOK commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTTB is a Hold and STOK is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
QTTB vs STOK: Fundamental Ratings
QTTB
STOK
OUTLOOK RATING
1..100
5560
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
1798
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
224
SEASONALITY SCORE
1..100
7541

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (46) in the null industry is somewhat better than the same rating for STOK (84). This means that QTTB’s stock grew somewhat faster than STOK’s over the last 12 months.

QTTB's Profit vs Risk Rating (98) in the null industry is in the same range as STOK (100). This means that QTTB’s stock grew similarly to STOK’s over the last 12 months.

QTTB's SMR Rating (17) in the null industry is significantly better than the same rating for STOK (98). This means that QTTB’s stock grew significantly faster than STOK’s over the last 12 months.

QTTB's Price Growth Rating (39) in the null industry is in the same range as STOK (64). This means that QTTB’s stock grew similarly to STOK’s over the last 12 months.

STOK's P/E Growth Rating (4) in the null industry is in the same range as QTTB (22). This means that STOK’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QTTBSTOK
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 2 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (QTTB: $8.25 vs. STOK: $26.01)
Brand notoriety: QTTB and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QTTB: 399% vs. STOK: 83%
Market capitalization -- QTTB: $274.77M vs. STOK: $1.65B
QTTB [@Biotechnology] is valued at $274.77M. STOK’s [@Biotechnology] market capitalization is $1.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTTB’s FA Score shows that 2 FA rating(s) are green while STOK’s FA Score has 1 green FA rating(s).

  • QTTB’s FA Score: 2 green, 3 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, QTTB is a better buy in the long-term than STOK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTTB’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • QTTB’s TA Score: 4 bullish, 5 bearish.
  • STOK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, QTTB is a better buy in the short-term than STOK.

Price Growth

QTTB (@Biotechnology) experienced а -10.52% price change this week, while STOK (@Biotechnology) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

QTTB is expected to report earnings on Nov 05, 2026.

STOK is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
QTTB
Daily Signal:
Gain/Loss:
STOK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALKT14.040.35
+2.56%
Alkami Technology
CVX207.102.89
+1.42%
Chevron Corp
VCTR111.741.14
+1.03%
Victory Capital Holdings
SEG22.74-0.15
-0.66%
Seaport Entertainment Group Inc
EHLD10.82-0.18
-1.64%
Euroholdings Ltd

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-0.24%
CLRB - QTTB
62%
Loosely correlated
+1.63%
MESO - QTTB
51%
Loosely correlated
-2.25%
STOK - QTTB
49%
Loosely correlated
+0.04%
IBRX - QTTB
40%
Loosely correlated
-1.69%
ANAB - QTTB
39%
Loosely correlated
-3.24%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with RCKT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+0.04%
RCKT - STOK
54%
Loosely correlated
-1.52%
QTTB - STOK
49%
Loosely correlated
-0.24%
SLDB - STOK
47%
Loosely correlated
-3.46%
TSHA - STOK
45%
Loosely correlated
-2.67%
CLDX - STOK
45%
Loosely correlated
-0.71%
More